Ph.D. Course in Drug Sciences (Corso di Dottorato di Ricerca in Scienze del Farmaco)
Coordinator: Prof. Marco Mor
Duration: 3 years
The Doctoral (Ph.D.) Course in Drug Sciences (Corso di Dottorato di Ricerca in Scienze del Farmaco, formerly "Corso di Dottorato di Ricerca in Scienze del Farmaco delle Biomolecole e dei Prodotti per la Salute)" is organized by the Department of Food and Drug at the University of Parma. Its programme consists of a research project, under supervision by a member of the Board of Teachers, and educational activities; it is concluded with the preparation and defense of a Ph.D. thesis.
The programme takes three years, during which changes of scientific environment are strongly encouraged. It awards a Doctoral Degree (titolo di Dottore di ricerca), a research degree based on scientific bases and research experience in the design, discovery, development, production and control of drugs as well as in the investigation of mechanisms of action for drugs and bioactive molecules. The Board of teachers offers and organizes courses and seminars in different scientific areas, with particular focus on medicinal chemistry, pharmaceutical chemistry, pharmacology and biochemistry.
The research project of each PhD student has to be consistent with a research line included in one of the major areas covered by the programme:
- drug design and synthesis;
- biopharmaceutics and pharmacokinetics;
- experimental pharmacology and toxicology;
- biochemistry, biophysics and molecular biology;
- bio-organic chemistry.
Ph.D. students, under the supervision of a member of the Board of Teachers, undertake a research project and follow specific courses and other educational activities. Educational activities concur to the accumulation of credits necessary to complete the Ph.D. Programme.
One ECTS credit (briefly, ECTS) can be achieved attending 6 hours of lessons or seminars, or participating to 1 day of National or International Schools or Workshops. For research activity, 1 ECTS corresponds to 25 hours (approximately 5 ECTS per month of full-time work).
To complete her/his 3-year Programme, a Ph.D. student must accumulate 180 ECTS, including at least 20 ECTS in educational activities. Educational ECTS are assigned by the speaker of the lesson/seminar, or by a member of the Board of Teachers, who checks the active participation by the Ph.D. Student.
A document certifying the activities accomplished during each year must be delivered by the Ph.D. Student to her/his Supervisor, who will present it to the Board of Teachers for admission to the next years of the Programme or to the final examination.
- Educational activities: 37th cycle
- Educational activities: 36th cycle
- Educational activities: 34 and 35th cycle
The COLOTAN (Boosting Advanced Doctoral Training in Innovative Colon Targeting Drugs) network (https://colotan-etn.eu) is an EU-funded Marie Sklodowska-Curie Innovative Training Network that will recruit and train 13 PhD students across Europe in drug delivery, drug disposition and gastrointestinal (patho)physiology to improve targeting of oral drugs to the colon. The international network, comprising 10 countries, shapes an intersectoral consortium, from academia to innovative pharmaceutical companies, whose background ranges from drug delivery to chemistry, cell biology, microbiology and gastroenterology.
One of the PhD project (ESR 13) will be supervised by the University of Parma (Department of Food and Drug, PhD in Drug Sciences).
Further details on this project and information are available at: https://colotan-etn.eu
ORBITAL Seminar Series Session for October 8, 2020
For full event details, simply click on the registration link here. Login details and calendar reminds can be accessed once you register.
The ORBITAL (Ocular Research By Integrated Training And Learning) network (https://www.orbital-itn.eu/) is an EU-funded Marie Sklodowska-Curie Innovation Training Network (MSCA-ITN). This ITN will recruit and train 15 early stage researchers (PhD students) across Europe to develop drug delivery technologies that can help treat posterior segment diseases of the eye. The network is built on an intersectoral consortium (academia, industry, clinicians, patient advocacy groups and hospitals) composed of 23 members from Europe, Canada and the US.
One of the PhD project (ESR13) will be co-supervised between Nanovector srl (Torino, Italy) the University of Parma (Department of Food and Drug, PhD in Drugs, Biomolecules and Health Products).
Further detail on this project and information on application can be found at: https://www.orbital-itn.eu/wp-content/uploads/2019/05/Project-13-informa...